LMOFX
Price
$41.02
Change
-$1.21 (-2.87%)
Updated
Feb 21 closing price
Net Assets
1.62B
VEXAX
Price
$144.57
Change
-$4.57 (-3.06%)
Updated
Feb 21 closing price
Net Assets
116.7B
Ad is loading...

LMOFX vs VEXAX

Header iconLMOFX vs VEXAX Comparison
Open Charts LMOFX vs VEXAXBanner chart's image
Patient Opportunity FI
Price$41.02
Change-$1.21 (-2.87%)
VolumeN/A
Net Assets1.62B
Vanguard Extended Market Index Admiral
Price$144.57
Change-$4.57 (-3.06%)
VolumeN/A
Net Assets116.7B
LMOFX vs VEXAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LMOFX vs. VEXAX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMOFX is a Hold and VEXAX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEXAX has more cash in the bank: 117B vs. LMOFX (1.62B). VEXAX pays higher dividends than LMOFX: VEXAX (1.20) vs LMOFX (0.00). LMOFX was incepted earlier than VEXAX: LMOFX (21 years) vs VEXAX (24 years). LMOFX is a more actively managed with annual turnover of: 40.00 vs. VEXAX (11.00). LMOFX has a lower initial minimum investment than VEXAX: LMOFX (0) vs VEXAX (3000). LMOFX annual gain was more profitable for investors over the last year : 25.83 vs. VEXAX (14.31). VEXAX return over 5 years is better than : 47.41 vs. LMOFX (37.47).
LMOFXVEXAXLMOFX / VEXAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence21 years24 years-
Gain YTD4.0590.3401,193%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.62B117B1%
Annual Yield % from dividends0.001.20-
Returns for 1 year25.8314.31180%
Returns for 3 years15.9721.1675%
Returns for 5 years37.4747.4179%
Returns for 10 years94.41115.9681%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALVO12.280.58
+4.96%
Alvotech
WEST6.350.10
+1.60%
Westrock Coffee Company
LPTX0.48N/A
-0.52%
Leap Therapeutics
LPLA372.13-7.33
-1.93%
LPL Financial Holdings
OPRX5.78-0.41
-6.62%
OptimizeRx Corp